Insmed Incorporated
INSM
$70.20
-$0.87-1.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.79% | 3.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.79% | 3.41% | |||
| Cost of Revenue | 23.53% | 0.98% | |||
| Gross Profit | 8.35% | 4.15% | |||
| SG&A Expenses | 19.83% | 11.60% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.67% | 6.03% | |||
| Operating Income | -23.38% | -7.31% | |||
| Income Before Tax | -6.73% | 26.77% | |||
| Income Tax Expenses | 24.85% | 21.00% | |||
| Earnings from Continuing Operations | -6.81% | 26.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.81% | 26.64% | |||
| EBIT | -23.38% | -7.31% | |||
| EBITDA | -23.63% | -7.39% | |||
| EPS Basic | -3.66% | 34.67% | |||
| Normalized Basic EPS | -18.01% | 6.97% | |||
| EPS Diluted | -3.61% | 34.64% | |||
| Normalized Diluted EPS | -18.01% | 6.97% | |||
| Average Basic Shares Outstanding | 3.05% | 12.29% | |||
| Average Diluted Shares Outstanding | 3.05% | 12.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||